Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Linking kinetochore attachment to checkpoint control: the role of Aurora B in BubR1 acetylation. | Nucleic Acids Res | 2026 | 41533580 | PubTator, text mining | PubMed |
| A novel variant p.Y250C of FZD4 influences Norrine/β-catenin signaling pathway that associates with familial exudative vitreoretinopathy (FEVR). | Sci Rep | 2026 | 41526591 | PubTator, text mining | PubMed |
| A comprehensive study integrating bioinformatics analysis and experimental results on HROB as a potential biomarker for the prognosis of lung adenocarcinoma. | Sci Rep | 2026 | 41526502 | PubTator, text mining | PubMed |
| Single-cell and machine learning-based analysis of the molecular mechanism of Banxia Xiexin Decoction in the treatment of gastric cancer. | Cytotechnology | 2026 | 41510325 | PubTator, text mining | PubMed |
| Insights into KIF11 pathogenesis in microcephaly-lymphedema-chorioretinopathy syndrome from a lymphatic perspective. | JCI Insight | 2026 | 41427784 | PubTator, text mining | PubMed |
| Analysis of familial exudative vitreoretinopathy (FEVR) cases in the UK 100 000 genomes project increases diagnostic rate and implicates heterozygous CTNND1 mutations in FEVR. | J Med Genet | 2026 | 41412793 | PubTator, text mining | PubMed |
| A combined study of network-based prediction and in vitro experimental validation on the procarcinogenic mechanism of propylparaben in estrogen receptor-positive breast cancer cells. | Ecotoxicol Environ Saf | 2026 | 41344141 | PubTator, text mining | PubMed |
| Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage. | Biochem Biophys Res Commun | 2026 | 41313943 | PubTator, text mining | PubMed |
| Novel Variant in the NLRP12 Gene: Insights From a Case Report and Systematic Review. | Int J Immunogenet | 2026 | 41261519 | PubTator, text mining | PubMed |
| Correspondence to "Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis". | Leukemia | 2026 | 41225181 | PubTator, text mining | PubMed |
| Enhancement Effects of α4/α6-Targeted Inhibitors on Eg5-Microtubule Interaction. | Proteins | 2026 | 41215706 | PubTator, text mining | PubMed |
| KIF11-related MCLMR presenting with FEVR-like retinopathy: first report in an Indian child. | Ophthalmic Genet | 2026 | 41068583 | PubTator, text mining | PubMed |
| Identification of exosome-related gene features in psoriasis and construction of a diagnostic model via integrated bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2026 | 39358990 | PubTator, text mining | PubMed |
| Integrative Bioinformatics and Experimental Validation Establish CCNB1 as a Potential Biomarker for Diagnosis and Prognosis in Colorectal Cancer. | Curr Issues Mol Biol | 2025 | 41614789 | PubTator, text mining | PubMed |
| Transcriptomics driven identification of hub gene miRNA interactions for biomarker and therapeutic target discovery in gynecological cancers. | Front Oncol | 2025 | 41561741 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Associated with the Development of Cervical Cancer. | Int J Mol Sci | 2025 | 41516135 | PubTator, text mining | PubMed |
| Targeted Regulation of Mitosis through Eg5 Protein Enhances Radiosensitivity of Renal Cell Carcinoma. | Arch Esp Urol | 2025 | 41492673 | PubTator, text mining | PubMed |
| Lineage-specific transcriptomic signatures and therapeutic target discovery in myeloid and lymphoid leukemias. | Per Med | 2025 | 41489186 | PubTator, text mining | PubMed |
| Network-based insights into miR-30a-5p-mediated regulation and EGCG targeting in triple-negative breast cancer. | Front Bioinform | 2025 | 41487287 | PubTator, text mining | PubMed |
| L-cystine alleviates necrotizing enterocolitis by regulating ferroptosis and Th17 cell differentiation via the IL-6/STAT3 pathway. | Commun Biol | 2025 | 41466058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=5